This month ALSF is showcasing the work of Dr. Mark Yarmarkovich on Peptide-Centric CAR T cells (https://www.alexslemonade.org/childhood-cancer/lectures).
1. Are these novel CAR T-cells the next therapeutic for solid tumors where success has been limited.
2. Dr. Yarmarkovich's model is pediatric Neuroblastoma. Will this apply to adult tumors?
3. Would the challenges faced with adult tumors be any different or more complex than pediatric tumors?
Share your thoughts and also listen in to Dr. Yarmarkovich's talk to share your thoughts during the webinar.
More Vidya Ganapathy's questions See All
Similar questions and discussions